United Health Products, Inc.
UEEC
$0.06
$0.00-7.14%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -67.87% | -36.26% | -44.80% | 343.62% | 130.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -66.30% | -40.50% | -33.76% | 250.32% | 75.82% |
| Operating Income | 66.30% | 40.50% | 33.76% | -250.32% | -75.82% |
| Income Before Tax | 34.05% | 5.96% | 27.04% | -238.95% | -72.52% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.05% | 5.96% | 27.04% | -238.95% | -72.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.05% | 5.96% | 27.04% | -238.95% | -72.52% |
| EBIT | 66.30% | 40.50% | 33.76% | -250.32% | -75.82% |
| EBITDA | 66.38% | 40.60% | 33.87% | -250.91% | -76.03% |
| EPS Basic | 34.38% | 8.33% | 29.41% | -233.33% | -68.42% |
| Normalized Basic EPS | 35.00% | 36.36% | 27.27% | -245.45% | -66.67% |
| EPS Diluted | 34.38% | 8.33% | 29.41% | -233.33% | -68.42% |
| Normalized Diluted EPS | 35.00% | 36.36% | 27.27% | -245.45% | -66.67% |
| Average Basic Shares Outstanding | 3.24% | 3.70% | 3.80% | 3.59% | 3.05% |
| Average Diluted Shares Outstanding | 3.24% | 3.70% | 3.80% | 3.59% | 3.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |